Add like
Add dislike
Add to saved papers

ANNALS EXPRESS: A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of post-operative acute kidney injury in patients with hepatocellular carcinoma.

BACKGROUND: The aspartate aminotransferase (AST) / alanine aminotransferase (ALT) ratio(AST/ALT) is an independent predictor of hepatic disease.

OBJECTIVES: To evaluate the association between pre-operative AST/ALT and post-operative acute kidney injury(AKI) in hepatocellular carcinoma (HCC) patients.

METHODS: A total of 422 hepatitis B- or C- virus associated HCC patients, who underwent hepatectomy between September 2012 and April 2018, were enrolled this retrospective study. From all patients, AST and ALT parameters were collected and the AST/ALT ratio was calculated. For diagnostic criteria of post-operative AKI, the Kidney Disease Improving Global Outcomes (KDIGO) criteria guidelines were used.

RESULTS: In 48 patients(11.4%), post-operative AKI was confirmed. In patients with post-operative AKI, the mean pre-operative serum AST/ALT was significantly higher when compared to patients without post-operative AKI. After multivariate logistic regression analysis, AST/ALT, hemoglobin, age, hypertension, Child-Turcotte-Pugh classification and the Milan criteria were all confirmed as predictive factors of postsurgical AKI. We found that an AST/ALT of 1.29 was the best cutoff point for predicting post-operative AKI. The positive predictive value (23.9%) of the cut-off is actually poor. After matching the propensity score, AST/ALT ≥1.29 was still confirmed as an independent predictor of post-operative AKI by multivariate analysis.

CONCLUSION: Pre-operative elevated serum AST/ALT may be a potential independent predictor of post-operative AKI in HCC patients who have undergone hepatectomy. This needs to be tested in further prospective studies.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app